Literature DB >> 28355610

Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy.

Ru Jia1, Petra Sulentic, Jian-Ming Xu, Ashley B Grossman.   

Abstract

Thymic neuroendocrine neoplasms are rare tumours, but their management can often be highly problematic. While previously assumed to be essentially variants of bronchopulmonary (lung) carcinoids, they are generally more aggressive and more difficult to treat. Some 25% are associated with multiple endocrine neoplasia-1, while a higher proportion are associated with the ectopic ACTH syndrome, and occasionally both. We discuss the classification of these tumours, their biology as far as is known, and their clinical, biochemical and imaging features. We also review possible management options and suggest stratagems to optimise their treatment, which even today is far from optimal.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Bronchopulmonary carcinoids; Carcinoid; Ectopic ACTH; Multiple endocrine neoplasia-1; Neuroendocrine tumour; Thymus

Mesh:

Year:  2017        PMID: 28355610     DOI: 10.1159/000472255

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  11 in total

Review 1.  Functional imaging in ectopic Cushing syndrome.

Authors:  Seda Grigoryan; Anca M Avram; Adina F Turcu
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-06       Impact factor: 3.243

Review 2.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

Review 3.  [Endocrine paraneoplastic syndromes].

Authors:  N Reisch; M Reincke
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

Review 4.  Chemotherapy in NETs: When and how.

Authors:  Anna Angelousi; Gregory Kaltsas; Anna Koumarianou; Martin O Weickert; Ashley Grossman
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 5.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

Review 6.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

7.  Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Iina Yliaska; Heikki Tokola; Tapani Ebeling; Outi Kuismin; Olavi Ukkola; Minna L Koivikko; Timo Lesonen; Jussi Rimpiläinen; Tuuli Felin; Eeva Ryhänen; Saara Metso; Camilla Schalin-Jäntti; Pasi Salmela
Journal:  Endocrine       Date:  2022-06-13       Impact factor: 3.925

8.  A Single Center Analysis of Thymic Neuroendocrine Tumors.

Authors:  Yirui Zhai; Qiang Zeng; Nan Bi; Zongmei Zhou; Zefen Xiao; Zhouguang Hui; Dongfu Chen; Luhua Wang; Jianyang Wang; Wenyang Liu; Lei Deng; Jima Lv; Wenqing Wang; Yang Luo; Junling Li; Xin Wang; Tao Zhang; Yushun Gao; Qinfu Feng
Journal:  Cancers (Basel)       Date:  2022-10-09       Impact factor: 6.575

9.  Ectopic Cushing's Syndrome secondary to Recurrent Thymic Neuroendocrine Carcinoma with Bilateral Ovarian Metastases: A Case Report.

Authors:  Eunice Yi Chwen Lau; Zanariah Hussein
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-05-04

10.  Comparison of 68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome.

Authors:  Virendra A Patil; Manjunath R Goroshi; Hina Shah; Gaurav Malhotra; Priya Hira; Vijaya Sarathi; Vikram R Lele; Swati Jadhav; Anurag Lila; Tushar R Bandgar; Nalini S Shah
Journal:  World J Nucl Med       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.